184 related articles for article (PubMed ID: 26508891)
1. Case report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumab.
Greenwood GT
Int Med Case Rep J; 2015; 8():235-9. PubMed ID: 26508891
[TBL] [Abstract][Full Text] [Related]
2. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.
Fakhouri F; Hourmant M; Campistol JM; Cataland SR; Espinosa M; Gaber AO; Menne J; Minetti EE; Provôt F; Rondeau E; Ruggenenti P; Weekers LE; Ogawa M; Bedrosian CL; Legendre CM
Am J Kidney Dis; 2016 Jul; 68(1):84-93. PubMed ID: 27012908
[TBL] [Abstract][Full Text] [Related]
3. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
Fakhouri F; Delmas Y; Provot F; Barbet C; Karras A; Makdassi R; Courivaud C; Rifard K; Servais A; Allard C; Besson V; Cousin M; Châtelet V; Goujon JM; Coindre JP; Laurent G; Loirat C; Frémeaux-Bacchi V
Am J Kidney Dis; 2014 Jan; 63(1):40-8. PubMed ID: 24021908
[TBL] [Abstract][Full Text] [Related]
4. Extra-Renal manifestations of atypical hemolytic uremic syndrome in children.
Fidan K; Göknar N; Gülhan B; Melek E; Yıldırım ZY; Baskın E; Hayran M; Gülleroglu K; Özçakar ZB; Ozaltin F; Soylemezoglu O
Pediatr Nephrol; 2018 Aug; 33(8):1395-1403. PubMed ID: 29610995
[TBL] [Abstract][Full Text] [Related]
5. Occlusive retinal vasculopathy with macular branch retinal artery occlusion as a leading sign of atypical hemolytic uremic syndrome - a case report.
González DP; Iglicki M; Svetitsky S; Bar-On Y; Habot-Wilner Z; Zur D
BMC Ophthalmol; 2021 Jan; 21(1):65. PubMed ID: 33516177
[TBL] [Abstract][Full Text] [Related]
6. Eculizumab Modifies Outcomes in Adults with Atypical Hemolytic Uremic Syndrome with Acute Kidney Injury.
Cao M; Leite BN; Ferreiro T; Calvo M; Fernández C; Alonso Á; Rodriguez A; Salvador P; Seijo R; Pita S; Arjona E; Rodríguez de Córdoba S; Valdés Cañedo F
Am J Nephrol; 2018; 48(3):225-233. PubMed ID: 30205388
[TBL] [Abstract][Full Text] [Related]
7. Eculizumab as first-line therapy for atypical hemolytic uremic syndrome.
Christmann M; Hansen M; Bergmann C; Schwabe D; Brand J; Schneider W
Pediatrics; 2014 Jun; 133(6):e1759-63. PubMed ID: 24843059
[TBL] [Abstract][Full Text] [Related]
8. An adult case of atypical hemolytic uremic syndrome presented with posterior reversible encephalopathy syndrome: Successful response to late-onset eculizumab treatment.
Medeni SS; Namdaroglu S; Cetintepe T; Ozlu C; Tasli F; Adibelli ZH; Bilgir O; Tatar E
Hematol Rep; 2018 Sep; 10(3):7553. PubMed ID: 30344987
[TBL] [Abstract][Full Text] [Related]
9. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
[TBL] [Abstract][Full Text] [Related]
10. Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis.
Povey H; Vundru R; Junglee N; Jibani M
Clin Nephrol; 2014 Nov; 82(5):326-31. PubMed ID: 23557793
[TBL] [Abstract][Full Text] [Related]
11. Atypical hemolytic-uremic syndrome due to complement factor I mutation.
Almalki AH; Sadagah LF; Qureshi M; Maghrabi H; Algain A; Alsaeed A
World J Nephrol; 2017 Nov; 6(6):243-250. PubMed ID: 29226095
[TBL] [Abstract][Full Text] [Related]
12. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
Sengul Samanci N; Ayer M; Ergen A; Ozturk S
Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of atypical hemolytic uremic syndrome and crescentic IgA nephropathy treated with eculizumab: a case report.
Matsumura D; Tanaka A; Nakamura T; Sato E; Node K
Clin Nephrol Case Stud; 2016; 4():24-28. PubMed ID: 29043138
[TBL] [Abstract][Full Text] [Related]
14. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.
Diamante Chiodini B; Davin JC; Corazza F; Khaldi K; Dahan K; Ismaili K; Adams B
Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055
[TBL] [Abstract][Full Text] [Related]
15. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
Andries G; Karass M; Yandrapalli S; Linder K; Liu D; Nelson J; Pawar R; Chugh S
Exp Hematol Oncol; 2017; 6():4. PubMed ID: 28101432
[TBL] [Abstract][Full Text] [Related]
16. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report.
Fontana F; Alfano G; Bardhushi E; Ligabue G; Giovanella S; Neri I; Cappelli G
Am J Case Rep; 2019 Oct; 20():1460-1465. PubMed ID: 31582717
[TBL] [Abstract][Full Text] [Related]
17. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
Greenbaum LA; Fila M; Ardissino G; Al-Akash SI; Evans J; Henning P; Lieberman KV; Maringhini S; Pape L; Rees L; van de Kar NC; Vande Walle J; Ogawa M; Bedrosian CL; Licht C
Kidney Int; 2016 Mar; 89(3):701-11. PubMed ID: 26880462
[TBL] [Abstract][Full Text] [Related]
18. Life-Threatening Extrarenal Manifestations in an Infant with Atypical Hemolytic Uremic Syndrome Caused by a Complement 3-Gene Mutation.
Han SR; Cho MH; Moon JS; Ha IS; Cheong HI; Kang HG
Kidney Blood Press Res; 2019; 44(5):1300-1305. PubMed ID: 31522186
[TBL] [Abstract][Full Text] [Related]
19. Atypical hemolytic uremic syndrome: a case report.
Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
[TBL] [Abstract][Full Text] [Related]
20. [Atypical hemolytic uremic syndrome].
Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
